Here's how OJRD.BIOMEDCENTRAL.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

OJRD . BIOMEDCENTRAL . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Ojrd.biomedcentral.com Make Money
  6. How Much Does Ojrd.biomedcentral.com Make
  7. Keywords
  8. Topics
  9. Questions
  10. Schema
  11. Social Networks
  12. External Links
  13. Analytics And Tracking
  14. Libraries
  15. CDN Services

We are analyzing https://ojrd.biomedcentral.com/articles/10.1186/s13023-025-03555-0.

Title:
Caregivers and multidisciplinary team members’ perspectives on shared decision making in Duchenne muscular dystrophy: A qualitative study | Orphanet Journal of Rare Diseases | Full Text
Description:
Background As new therapies for Duchenne muscular dystrophy (DMD) are entering the market, shared decision making (SDM) will become increasingly important. Therefore, this study aimed to understand (1) Belgian stakeholders’ knowledge and perceptions of SDM in DMD treatment decision making, (2) the current state of SDM implementation in DMD in Belgium, examining the role of all involved parties, and (3) the barriers and facilitators for SDM in DMD in the Belgian context. Methods In this qualitative study, semi-structured interviews with the multidisciplinary team (MDT) of individuals with DMD (n = 18) and caregivers thereof (n = 11) were conducted in Belgium. Qualitative data was analyzed thematically using the framework method. Results Most caregivers were unfamiliar with the term SDM, while MDT members were aware of it but struggled to define it consistent with existing literature. Despite acknowledging some drawbacks, participants valued SDM as an important process in DMD care, noting its presence in current practice. However, both MDT members and caregivers sometimes questioned the necessity of SDM due to limited treatment options available. Consequently, decision making predominantly relied on (child) neurologists sharing information and seeking consent from caregivers and individuals with DMD for a proposed treatment. Participants highlighted the important role of the MDT, with each professional contributing its unique expertise to SDM. To reduce existing barriers and enhance the SDM process, participants called for clear and transparent information regarding different treatment options, including clinical trials, and detailed information on how treatments might affect patients’ daily life. Conclusion This study identified an increased need for easily understandable information, particularly regarding DMD care in general, but also about clinical trials covering new and emerging therapies. Developing specific evidence-based tools could support stakeholders’ understanding of this information, thereby enhancing implementation of the SDM process in DMD care. Further, as the treatment landscape of DMD evolves, it will become increasingly important for patients to be supported by an MDT, as they can provide information on clinical trials (e.g., study coordinators), emotional support (e.g., psychologists, nurses), and decisional guidance (e.g., neurologist).
Website Age:
25 years and 10 months (reg. 1999-08-06).

Matching Content Categories {📚}

  • Education
  • Insurance
  • Family & Parenting

Content Management System {📝}

What CMS is ojrd.biomedcentral.com built with?

Custom-built

No common CMS systems were detected on Ojrd.biomedcentral.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of ojrd.biomedcentral.com audience?

🚀 Good Traffic: 50k - 100k visitors per month


Based on our best estimate, this website will receive around 50,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Ojrd.biomedcentral.com Make Money? {💸}


Display Ads {🎯}


The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.

Ads are managed by yourbow.com. Particular relationships are as follows:

Direct Advertisers (3)
yourbow.com, google.com, doceree.com

How Much Does Ojrd.biomedcentral.com Make? {💰}


Display Ads {🎯}

$690 per month
According to our algorithms, Ojrd.biomedcentral.com's monthly online income from display advertising ranges from $462 to $1,271.

Keywords {🔍}

sdm, dmd, caregivers, information, treatment, mdt, decision, study, individuals, participants, clinical, patients, process, care, making, duchenne, belgium, members, interviews, shared, patient, muscular, dystrophy, options, decisionmaking, research, article, role, practice, trials, decisions, health, child, involved, hcps, approach, leuven, data, team, therapies, implementation, barriers, support, model, caregiver, questions, hcp, therapy, included, internet,

Topics {✒️}

gov/news-events/press-announcements/fda-approves-targeted-treatment-rare-duchenne-muscular-dystrophy-mutation-0 food gov/news-events/press-announcements/fda-grants-accelerated-approval targeted-treatment-rare-duchenne-muscular-dystrophy-mutation food org/pediatrics/article-pdf/142/supplement_2/s5/905113/peds_20180333c %20diagnosis%2c%20treatment%20and%20counseling cosyns electronic supplementary material query=duchenne+muscular+dystrophy geuens drug-duchenne-muscular-dystrophy food data availability eu/ctr-search/search classify sections liesbeth de waele abbreviations coreq net/docs/ejprd-cosyns %20neuromuscular%20reference%20centre%20is engagement funding duchenne muscular dystrophy open discussion e-mail addresses publicly enhances professional-patient relationships developing evidence-based tools additional information publisher caregiver-proxy viewpoints central multi-disciplinary health research supplementary questions related shared decision-making [internet] obtain open-ended responses research rosanne janssens pre-empting future discussions human rights potentially time-consuming nature state privacy rights rare diseases home providing evidence-based information evidence-based information tools pediatric shared decision-making pdf osorio received corticosteroid treatment facilitating patient-centered care rare disease caused chantal van audenhove van der weijden sam geuens implementing shared decision-making provide evidence-based information privacy choices/manage cookies targeted treatment bmc pediatrics european economic area

Questions {❓}

  • Charles C, Gafnv A, Whelan T, SHARED DECISION-MAKING IN, THE MEDICAL ENCOUNTER: WHAT DOES IT MEAN?
  • For which decisions is Shared decision making considered appropriate?
  • How are decisions made in cancer care?
  • Physician as partner or salesman?
  • What information do patients want about their medicines?
  • Where is the evidence?
  • Eu/ctr-search/search?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Caregivers and multidisciplinary team members’ perspectives on shared decision making in Duchenne muscular dystrophy: A qualitative study
         description:As new therapies for Duchenne muscular dystrophy (DMD) are entering the market, shared decision making (SDM) will become increasingly important. Therefore, this study aimed to understand (1) Belgian stakeholders’ knowledge and perceptions of SDM in DMD treatment decision making, (2) the current state of SDM implementation in DMD in Belgium, examining the role of all involved parties, and (3) the barriers and facilitators for SDM in DMD in the Belgian context. In this qualitative study, semi-structured interviews with the multidisciplinary team (MDT) of individuals with DMD (n = 18) and caregivers thereof (n = 11) were conducted in Belgium. Qualitative data was analyzed thematically using the framework method. Most caregivers were unfamiliar with the term SDM, while MDT members were aware of it but struggled to define it consistent with existing literature. Despite acknowledging some drawbacks, participants valued SDM as an important process in DMD care, noting its presence in current practice. However, both MDT members and caregivers sometimes questioned the necessity of SDM due to limited treatment options available. Consequently, decision making predominantly relied on (child) neurologists sharing information and seeking consent from caregivers and individuals with DMD for a proposed treatment. Participants highlighted the important role of the MDT, with each professional contributing its unique expertise to SDM. To reduce existing barriers and enhance the SDM process, participants called for clear and transparent information regarding different treatment options, including clinical trials, and detailed information on how treatments might affect patients’ daily life. This study identified an increased need for easily understandable information, particularly regarding DMD care in general, but also about clinical trials covering new and emerging therapies. Developing specific evidence-based tools could support stakeholders’ understanding of this information, thereby enhancing implementation of the SDM process in DMD care. Further, as the treatment landscape of DMD evolves, it will become increasingly important for patients to be supported by an MDT, as they can provide information on clinical trials (e.g., study coordinators), emotional support (e.g., psychologists, nurses), and decisional guidance (e.g., neurologist).
         datePublished:2025-03-10T00:00:00Z
         dateModified:2025-03-10T00:00:00Z
         pageStart:1
         pageEnd:13
         license:http://creativecommons.org/publicdomain/zero/1.0/
         sameAs:https://doi.org/10.1186/s13023-025-03555-0
         keywords:
            Duchenne muscular dystrophy
            Interprofessional model of shared decision making
            Patient decision aids
            Informational needs
            Multidisciplinary team
            Patient engagement
            Medicine/Public Health
            general
            Pharmacology/Toxicology
            Human Genetics
         image:
         isPartOf:
            name:Orphanet Journal of Rare Diseases
            issn:
               1750-1172
            volumeNumber:20
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Elise Schoefs
               url:http://orcid.org/0000-0003-3542-6936
               affiliation:
                     name:KU Leuven
                     address:
                        name:Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Thomas Desmet
               url:http://orcid.org/0000-0001-7630-4850
               affiliation:
                     name:KU Leuven
                     address:
                        name:Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium
                        type:PostalAddress
                     type:Organization
                     name:Vlerick Business School
                     address:
                        name:Healthcare Management Centre, Vlerick Business School, Ghent, Belgium
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Evelyn Lerinckx
               affiliation:
                     name:KU Leuven
                     address:
                        name:Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium
                        type:PostalAddress
                     type:Organization
                     name:Pfizer NV
                     address:
                        name:Pfizer NV, Elsene, Belgium
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Liesbeth De Waele
               url:http://orcid.org/0000-0001-7126-575X
               affiliation:
                     name:University Hospitals Leuven
                     address:
                        name:Department of Child Neurology, University Hospitals Leuven, Leuven, Belgium
                        type:PostalAddress
                     type:Organization
                     name:KU Leuven
                     address:
                        name:Department of Development and Regeneration, KU Leuven, Leuven, Belgium
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Sam Geuens
               url:http://orcid.org/0000-0003-4527-9319
               affiliation:
                     name:University Hospitals Leuven
                     address:
                        name:Department of Child Neurology, University Hospitals Leuven, Leuven, Belgium
                        type:PostalAddress
                     type:Organization
                     name:KU Leuven
                     address:
                        name:Department of Development and Regeneration, KU Leuven, Leuven, Belgium
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Conny Pelicaen
               affiliation:
                     name:Duchenne Parent Project Belgium
                     address:
                        name:Duchenne Parent Project Belgium, Haacht, Belgium
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Luc Meeus
               affiliation:
                     name:Duchenne Parent Project Belgium
                     address:
                        name:Duchenne Parent Project Belgium, Haacht, Belgium
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Steven Simoens
               url:http://orcid.org/0000-0002-9512-2005
               affiliation:
                     name:KU Leuven
                     address:
                        name:Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Chantal Van Audenhove
               url:http://orcid.org/0000-0002-5504-5439
               affiliation:
                     name:KU Leuven
                     address:
                        name:Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mieke Mommen
               affiliation:
                     name:Pfizer NV
                     address:
                        name:Pfizer NV, Elsene, Belgium
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Rosanne Janssens
               url:http://orcid.org/0000-0003-1982-4176
               affiliation:
                     name:KU Leuven
                     address:
                        name:Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Isabelle Huys
               url:http://orcid.org/0000-0002-4738-8298
               affiliation:
                     name:KU Leuven
                     address:
                        name:Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Caregivers and multidisciplinary team members’ perspectives on shared decision making in Duchenne muscular dystrophy: A qualitative study
      description:As new therapies for Duchenne muscular dystrophy (DMD) are entering the market, shared decision making (SDM) will become increasingly important. Therefore, this study aimed to understand (1) Belgian stakeholders’ knowledge and perceptions of SDM in DMD treatment decision making, (2) the current state of SDM implementation in DMD in Belgium, examining the role of all involved parties, and (3) the barriers and facilitators for SDM in DMD in the Belgian context. In this qualitative study, semi-structured interviews with the multidisciplinary team (MDT) of individuals with DMD (n = 18) and caregivers thereof (n = 11) were conducted in Belgium. Qualitative data was analyzed thematically using the framework method. Most caregivers were unfamiliar with the term SDM, while MDT members were aware of it but struggled to define it consistent with existing literature. Despite acknowledging some drawbacks, participants valued SDM as an important process in DMD care, noting its presence in current practice. However, both MDT members and caregivers sometimes questioned the necessity of SDM due to limited treatment options available. Consequently, decision making predominantly relied on (child) neurologists sharing information and seeking consent from caregivers and individuals with DMD for a proposed treatment. Participants highlighted the important role of the MDT, with each professional contributing its unique expertise to SDM. To reduce existing barriers and enhance the SDM process, participants called for clear and transparent information regarding different treatment options, including clinical trials, and detailed information on how treatments might affect patients’ daily life. This study identified an increased need for easily understandable information, particularly regarding DMD care in general, but also about clinical trials covering new and emerging therapies. Developing specific evidence-based tools could support stakeholders’ understanding of this information, thereby enhancing implementation of the SDM process in DMD care. Further, as the treatment landscape of DMD evolves, it will become increasingly important for patients to be supported by an MDT, as they can provide information on clinical trials (e.g., study coordinators), emotional support (e.g., psychologists, nurses), and decisional guidance (e.g., neurologist).
      datePublished:2025-03-10T00:00:00Z
      dateModified:2025-03-10T00:00:00Z
      pageStart:1
      pageEnd:13
      license:http://creativecommons.org/publicdomain/zero/1.0/
      sameAs:https://doi.org/10.1186/s13023-025-03555-0
      keywords:
         Duchenne muscular dystrophy
         Interprofessional model of shared decision making
         Patient decision aids
         Informational needs
         Multidisciplinary team
         Patient engagement
         Medicine/Public Health
         general
         Pharmacology/Toxicology
         Human Genetics
      image:
      isPartOf:
         name:Orphanet Journal of Rare Diseases
         issn:
            1750-1172
         volumeNumber:20
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Elise Schoefs
            url:http://orcid.org/0000-0003-3542-6936
            affiliation:
                  name:KU Leuven
                  address:
                     name:Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Thomas Desmet
            url:http://orcid.org/0000-0001-7630-4850
            affiliation:
                  name:KU Leuven
                  address:
                     name:Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium
                     type:PostalAddress
                  type:Organization
                  name:Vlerick Business School
                  address:
                     name:Healthcare Management Centre, Vlerick Business School, Ghent, Belgium
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Evelyn Lerinckx
            affiliation:
                  name:KU Leuven
                  address:
                     name:Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium
                     type:PostalAddress
                  type:Organization
                  name:Pfizer NV
                  address:
                     name:Pfizer NV, Elsene, Belgium
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Liesbeth De Waele
            url:http://orcid.org/0000-0001-7126-575X
            affiliation:
                  name:University Hospitals Leuven
                  address:
                     name:Department of Child Neurology, University Hospitals Leuven, Leuven, Belgium
                     type:PostalAddress
                  type:Organization
                  name:KU Leuven
                  address:
                     name:Department of Development and Regeneration, KU Leuven, Leuven, Belgium
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Sam Geuens
            url:http://orcid.org/0000-0003-4527-9319
            affiliation:
                  name:University Hospitals Leuven
                  address:
                     name:Department of Child Neurology, University Hospitals Leuven, Leuven, Belgium
                     type:PostalAddress
                  type:Organization
                  name:KU Leuven
                  address:
                     name:Department of Development and Regeneration, KU Leuven, Leuven, Belgium
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Conny Pelicaen
            affiliation:
                  name:Duchenne Parent Project Belgium
                  address:
                     name:Duchenne Parent Project Belgium, Haacht, Belgium
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Luc Meeus
            affiliation:
                  name:Duchenne Parent Project Belgium
                  address:
                     name:Duchenne Parent Project Belgium, Haacht, Belgium
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Steven Simoens
            url:http://orcid.org/0000-0002-9512-2005
            affiliation:
                  name:KU Leuven
                  address:
                     name:Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Chantal Van Audenhove
            url:http://orcid.org/0000-0002-5504-5439
            affiliation:
                  name:KU Leuven
                  address:
                     name:Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mieke Mommen
            affiliation:
                  name:Pfizer NV
                  address:
                     name:Pfizer NV, Elsene, Belgium
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Rosanne Janssens
            url:http://orcid.org/0000-0003-1982-4176
            affiliation:
                  name:KU Leuven
                  address:
                     name:Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Isabelle Huys
            url:http://orcid.org/0000-0002-4738-8298
            affiliation:
                  name:KU Leuven
                  address:
                     name:Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Orphanet Journal of Rare Diseases
      issn:
         1750-1172
      volumeNumber:20
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:KU Leuven
      address:
         name:Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium
         type:PostalAddress
      name:KU Leuven
      address:
         name:Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium
         type:PostalAddress
      name:Vlerick Business School
      address:
         name:Healthcare Management Centre, Vlerick Business School, Ghent, Belgium
         type:PostalAddress
      name:KU Leuven
      address:
         name:Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium
         type:PostalAddress
      name:Pfizer NV
      address:
         name:Pfizer NV, Elsene, Belgium
         type:PostalAddress
      name:University Hospitals Leuven
      address:
         name:Department of Child Neurology, University Hospitals Leuven, Leuven, Belgium
         type:PostalAddress
      name:KU Leuven
      address:
         name:Department of Development and Regeneration, KU Leuven, Leuven, Belgium
         type:PostalAddress
      name:University Hospitals Leuven
      address:
         name:Department of Child Neurology, University Hospitals Leuven, Leuven, Belgium
         type:PostalAddress
      name:KU Leuven
      address:
         name:Department of Development and Regeneration, KU Leuven, Leuven, Belgium
         type:PostalAddress
      name:Duchenne Parent Project Belgium
      address:
         name:Duchenne Parent Project Belgium, Haacht, Belgium
         type:PostalAddress
      name:Duchenne Parent Project Belgium
      address:
         name:Duchenne Parent Project Belgium, Haacht, Belgium
         type:PostalAddress
      name:KU Leuven
      address:
         name:Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium
         type:PostalAddress
      name:KU Leuven
      address:
         name:Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium
         type:PostalAddress
      name:Pfizer NV
      address:
         name:Pfizer NV, Elsene, Belgium
         type:PostalAddress
      name:KU Leuven
      address:
         name:Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium
         type:PostalAddress
      name:KU Leuven
      address:
         name:Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Elise Schoefs
      url:http://orcid.org/0000-0003-3542-6936
      affiliation:
            name:KU Leuven
            address:
               name:Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Thomas Desmet
      url:http://orcid.org/0000-0001-7630-4850
      affiliation:
            name:KU Leuven
            address:
               name:Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium
               type:PostalAddress
            type:Organization
            name:Vlerick Business School
            address:
               name:Healthcare Management Centre, Vlerick Business School, Ghent, Belgium
               type:PostalAddress
            type:Organization
      name:Evelyn Lerinckx
      affiliation:
            name:KU Leuven
            address:
               name:Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium
               type:PostalAddress
            type:Organization
            name:Pfizer NV
            address:
               name:Pfizer NV, Elsene, Belgium
               type:PostalAddress
            type:Organization
      name:Liesbeth De Waele
      url:http://orcid.org/0000-0001-7126-575X
      affiliation:
            name:University Hospitals Leuven
            address:
               name:Department of Child Neurology, University Hospitals Leuven, Leuven, Belgium
               type:PostalAddress
            type:Organization
            name:KU Leuven
            address:
               name:Department of Development and Regeneration, KU Leuven, Leuven, Belgium
               type:PostalAddress
            type:Organization
      name:Sam Geuens
      url:http://orcid.org/0000-0003-4527-9319
      affiliation:
            name:University Hospitals Leuven
            address:
               name:Department of Child Neurology, University Hospitals Leuven, Leuven, Belgium
               type:PostalAddress
            type:Organization
            name:KU Leuven
            address:
               name:Department of Development and Regeneration, KU Leuven, Leuven, Belgium
               type:PostalAddress
            type:Organization
      name:Conny Pelicaen
      affiliation:
            name:Duchenne Parent Project Belgium
            address:
               name:Duchenne Parent Project Belgium, Haacht, Belgium
               type:PostalAddress
            type:Organization
      name:Luc Meeus
      affiliation:
            name:Duchenne Parent Project Belgium
            address:
               name:Duchenne Parent Project Belgium, Haacht, Belgium
               type:PostalAddress
            type:Organization
      name:Steven Simoens
      url:http://orcid.org/0000-0002-9512-2005
      affiliation:
            name:KU Leuven
            address:
               name:Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium
               type:PostalAddress
            type:Organization
      name:Chantal Van Audenhove
      url:http://orcid.org/0000-0002-5504-5439
      affiliation:
            name:KU Leuven
            address:
               name:Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium
               type:PostalAddress
            type:Organization
      name:Mieke Mommen
      affiliation:
            name:Pfizer NV
            address:
               name:Pfizer NV, Elsene, Belgium
               type:PostalAddress
            type:Organization
      name:Rosanne Janssens
      url:http://orcid.org/0000-0003-1982-4176
      affiliation:
            name:KU Leuven
            address:
               name:Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium
               type:PostalAddress
            type:Organization
      name:Isabelle Huys
      url:http://orcid.org/0000-0002-4738-8298
      affiliation:
            name:KU Leuven
            address:
               name:Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium
      name:Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium
      name:Healthcare Management Centre, Vlerick Business School, Ghent, Belgium
      name:Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium
      name:Pfizer NV, Elsene, Belgium
      name:Department of Child Neurology, University Hospitals Leuven, Leuven, Belgium
      name:Department of Development and Regeneration, KU Leuven, Leuven, Belgium
      name:Department of Child Neurology, University Hospitals Leuven, Leuven, Belgium
      name:Department of Development and Regeneration, KU Leuven, Leuven, Belgium
      name:Duchenne Parent Project Belgium, Haacht, Belgium
      name:Duchenne Parent Project Belgium, Haacht, Belgium
      name:Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium
      name:Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium
      name:Pfizer NV, Elsene, Belgium
      name:Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium
      name:Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium

External Links {🔗}(114)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Moment.js
  • Prism.js

CDN Services {📦}

  • Crossref

3.92s.